Blenrep

by GlaxoSmithKline (GSK)

Blenrep is a targeted antibody-drug conjugate for relapsed or refractory multiple myeloma available through the Together with GSK patient assistance program.

What is Blenrep?

Blenrep (belantamab mafodotin) is a BCMA-directed antibody-drug conjugate (ADC) approved for adults with relapsed or refractory multiple myeloma who have received at least four prior therapies including an anti-CD38 monoclonal antibody, a proteasome inhibitor, and an immunomodulatory agent. It delivers a cytotoxic payload directly to myeloma cells that express the BCMA protein. Blenrep is administered as an intravenous infusion at certified healthcare facilities.

Important: Blenrep can cause serious eye problems (keratopathy), which can impair vision. Patients must have eye exams before each dose and enroll in the BLENREP REMS (Risk Evaluation and Mitigation Strategy) program before starting treatment. Prescribers, treatment centers, and patients must all be enrolled in REMS.

Patient Assistance Program

Eligible patients may receive Blenrep at no cost through Together with GSK. ClariMeds handles all application paperwork at no charge.

Eligibility

  • U.S. resident with a valid prescription from an enrolled REMS prescriber
  • Uninsured or underinsured
  • Meets household income requirements

Patient assistance programs

Together with GSK (GSK Patient Assistance Program)

Manufacturer PAP
Eligibility
Uninsured or underinsured U.S. residents with relapsed/refractory multiple myeloma, a valid prescription, and REMS enrollment who meet income requirements.
Income limit
Varies based on household size; generally ≤400% of Federal Poverty Level (FPL)
Insurance
Uninsured or underinsured; insurance must not adequately cover Blenrep
How to apply
Apply through ClariMeds — we handle all paperwork at no cost to you. REMS enrollment is required before treatment can begin. Applications are submitted to GSK on your behalf.

Need help applying?

ClariMeds handles the entire application process for you — for free. See if you qualify in minutes.

See If You Qualify — Free